This document sets out standards for training in Interventional Neuroradiology (INR) in Europe. These standards have been developed by a working group of the European Society of Neuroradiology ... Show moreThis document sets out standards for training in Interventional Neuroradiology (INR) in Europe. These standards have been developed by a working group of the European Society of Neuroradiology (ESNR) and the European Society of Minimally Invasive Neurological Therapy (ESMINT) on the initiative and under the umbrella of the Division of Neuroradiology/Section of Radiology of the European Union of Medical Specialists (UEMS). Show less
Beyer, T.; Rijswijk, C.S.P. van; Villagran, J.M.; Rehnitz, C.; Muto, M.; Falck, C. von; ... ; Weber, M.A. 2019
PurposeTo evaluate technical success and long-term outcome of CT-guided radiofrequency ablation (RFA) of spinal osteoid osteomas (OO) and osteoblastomas (OB) in six different European centres... Show morePurposeTo evaluate technical success and long-term outcome of CT-guided radiofrequency ablation (RFA) of spinal osteoid osteomas (OO) and osteoblastomas (OB) in six different European centres.MethodsEighty-seven patients with spinal OO (77) or OB (10) were treated with CT-guided RFA, after three-dimensional CT-guided access planning. Patient's long-term outcome was assessed by clinical examination and questionnaire-based evaluation including 10-point visual analogue scales (VAS) regarding the effect of RFA on severity of pain and limitations of daily activities. Clinical success was defined as a reduction of >30% in the VAS score and patient's satisfaction.ResultsOverall, RFA was technically successful in 82/87 cases (94.3%) with no major complications; clinical success was achieved in 78/87 cases (89.7%). The OO/OB were localized in the cervical (n=9/3), the thoracic (n=27/1), the lumbar (n=29/4), and the sacral spine (n=12/2). A decrease in severity of pain after RFA was observed in 86/87 patients (98.9%) with a persistent mean reduction of overall pain score from 8.040.96 to 1.46 +/- 1.95 (p<0.001) after a median follow-up time of 29.35 +/- 35.59months. VAS scores significantly decreased for limitations of both daily (5.70 +/- 2.73 to 0.67 +/- 1.61, p<0.001) and sports activities (6.40 +/- 2.58 to 0.67 +/- 1.61, p<0.001).Conclusion In a multicentric setting, this trial proves RFA to be a safe and efficient method to treat spinal OO/OB and should be regarded as first-line therapy after interdisciplinary case discussion. Show less
